Principal Financial Group
CRNX icon

Principal Financial Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Principal Financial Group’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Buy
7,930
+864
+12% +$32.1K ﹤0.01% 2053
2026
Q1 		$257K Buy
7,066
+1,725
+32% +$77K ﹤0.01% 2085
2025
Q4 		$249K Sell
5,341
-1,582
-23% -$70.4K ﹤0.01% 2109
2025
Q3 		$288K Buy
+6,923
New +$221K ﹤0.01% 2124
2025
Q2 		– Sell
-81,184
Closed -$2.72M – 2241
2025
Q1 		$2.72M Buy
81,184
+28
+0% +$1.05K ﹤0.01% 1714
2024
Q4 		$4.15M Buy
81,156
+3,447
+4% +$193K ﹤0.01% 1643
2024
Q3 		$3.97M Buy
77,709
+64,504
+488% +$3.33M ﹤0.01% 1633
2024
Q2 		$591K Sell
13,205
-1,771
-12% -$81.8K ﹤0.01% 1918
2024
Q1 		$701K Sell
14,976
-909
-6% -$35.6K ﹤0.01% 1923
2023
Q4 		$565K Sell
15,885
-1,416
-8% -$43.4K ﹤0.01% 1939
2023
Q3 		$515K Buy
17,301
+3,649
+27% +$75.2K ﹤0.01% 1943
2023
Q2 		$246K Sell
13,652
-336
-2% -$6.7K ﹤0.01% 2127
2023
Q1 		$225K Buy
13,988
+1,654
+13% +$30.6K ﹤0.01% 2153
2022
Q4 		$226K Buy
+12,334
New +$217K ﹤0.01% 2167
2022
Q1 		– Sell
-7,295
Closed -$207K – 2559
2021
Q4 		$207K Buy
+7,295
New +$180K ﹤0.01% 2353

Other funds holding CRNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
BSA
Braun Stacey Associates New York $3.53B AUM 63.32% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Principal Financial Group's CRNX Position: Q2 2026 in Review

Principal Financial Group increased its Crinetics Pharmaceuticals (CRNX) stake by 12% in Q2 2026, buying an estimated $32.1K and bringing the position to 7,930 shares worth $297K. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Principal Financial Group first reported a position in CRNX in Q4 2021 and has held it in 15 quarters since. The position peaked at $4.15M in Q4 2024. 100 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Principal Financial Group held 7,930 shares of Crinetics Pharmaceuticals worth $297K as of Q2 2026.
  • Principal Financial Group bought 864 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $32.1K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #2053 holding.
  • Principal Financial Group first reported a position in Crinetics Pharmaceuticals in Q4 2021 and has held it in 15 quarters since.
  • Principal Financial Group's Crinetics Pharmaceuticals position peaked at $4.15M in Q4 2024.
  • 100 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.